Pericytes in kidney fibrosis

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 4, 2013, Pages 471-480

  Ren, Shuyu ^a   Duffield, Jeremy S ^a  

^a Center for Lung Biology   (United States)

Author keywords

Ephrin; Fibrosis; Pericyte; TGF ; WNT

Indexed keywords

ADAM PROTEIN; EPHRIN; ERYTHROPOIETIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MICRORNA; MICRORNA 21; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; WNT1 PROTEIN;

ADIPOCYTE; ADIPOGENESIS; CATALYSIS; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; DIABETIC NEPHROPATHY; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; GLOMERULUS CAPILLARY; HUMAN; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MACROPHAGE; MYOFIBROBLAST; NONHUMAN; PERICYTE; PRIORITY JOURNAL; REVIEW; STELLATE CELL; VASCULAR ENDOTHELIUM;

ANIMALS; CELL TRANSDIFFERENTIATION; FIBRILLAR COLLAGENS; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; MATRIX METALLOPROTEINASES; MICRORNAS; MYOFIBROBLASTS; PERICYTES; SIGNAL TRANSDUCTION;

EID: 84879228156     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328362485e     Document Type: Review

References (54)

1. Venkatachalam MA, Griffin KA, Lan R, et al. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 2010; 298:F1078-F1094.
2. Humphreys BD, Lin SL, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176:85-97.
3. Bielesz B, Sirin Y, Si H, et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120:4040-4054.
4. Koesters R, Kaissling B, Lehir M, et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010; 177:632-643.
5. Jabs A, Moncada GA, Nichols CE, et al. Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue. J Vasc Res 2005; 42:174-180.
6. Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952-961.
7. Campanholle G, Ligestri G, Gharib SA, Duffield JS. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol 2013; 304:C591-603.
8. Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 2013; 5:167sr1.
9. Duffield JS. The elusive source of myofibroblasts: problem solved? Nat Med 2012; 18:1178-1180.
10. Duffield JS, Lupher M, Thannickal VJ, Wynn TA. Host responses in tissue repair and fibrosis. Annu Rev Pathol 2013; 8:241-276.
11. Scholten D, Osterreicher CH, Scholten A, et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 2010; 139:987-998.
12. Taura K, Miura K, Iwaisako K, et al. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 2010; 51:1027-1036.
13. Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173:1617-1627.
14. Rock JR, Barkauskas CE, Cronce MJ, et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A 2011; 108:E1475-1483.
15. Goritz C, Dias DO, Tomilin N, et al. A pericyte origin of spinal cord scar tissue. Science 2011; 333:238-242.
16. Peduto L, Reuter VE, Sehara-Fujisawa A, et al. ADAM 12 ishighly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression. Oncogene 2006; 25:5462-5466.
17. Dulauroy S, Di Carlo SE, Langa F, et al. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012. [Epub ahead of print]
18. Rojas A, Chang FC, Lin SL, Duffield JS. The role played by perivascular cells in kidney interstitial injury. Clin Nephrol 2012; 77:400-408.
19. Asada N, Takase M, Nakamura J, et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 2011; 121:3981-3990.
20. Hellerbrand C. Hepatic stellate cells: the pericytes in the liver. Pflugers Arch 2013. [Epub ahead of print]
21. Dranoff JA, Wells RG. Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 2010; 51:1438-1444.
22. Walker N, Badri L, Wettlaufer S, et al. Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. Am J Pathol 2011; 178:2461-2469.
23. Smith CL, Tallquist MD. PDGF function in diverse neural crest cell populations. Cell Adh Migr 2010; 4:561-566.
24. Wu CF, Chiang WC, Lai CF, et al. Transforming growth factor beta-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. Am J Pathol 2013; 182:118-131.
25. Schrimpf C, Xin C, Campanholle G, et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 2012; 23:868-883.
26. Chen YT, Chang FC, Wu CF, et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and postischemic kidney fibrosis. Kidney Int 2011; 80:1170-1181.
27. Ren S, Johnson BG, Kida Y, et al. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci U S A 2013; 110:1440-1445.
28. Joe AW, Yi L, Natarajan A, et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 2010; 12:153-163.
29. Uezumi A, Fukada S, Yamamoto N, et al. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 2010; 12:143-152.
30. Uezumi A, Ito T, Morikawa D, et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci 2011; 124:3654-3664.
31. Woroniecka KI, Park AS, Mohtat D, et al. Transcriptome analysis of human diabetic kidney disease. Diabetes 2011; 60:2354-2369.
32. He JC, Chuang PY, Ma'ayan A, Iyengar R. Systems biology of kidney diseases. Kidney Int 2012; 81:22-39.
33. Shkreli M, Sarin KY, Pech MF, et al. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med 2012; 18:111-119.
34. Wang D, Dai C, Li Y, Liu Y. Canonical Wnt/beta-catenin signaling mediates transforming growth factor-beta1-driven podocyte injury and proteinuria. Kidney Int 2011; 80:1159-1169.
35. Alpers CE, Seifert RA, Hudkins KL, et al. PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int 1993; 43:286-294.
36. Smith SW, Eardley KS, Croft AP, et al. CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int 2011; 80:199-207.
37. Simonavicius N, Ashenden M, van Weverwijk A, et al. Pericytes promote selective vessel regression to regulate vascular patterning. Blood 2012; 120:1516-1527.
38. Becker R, Lenter MC, Vollkommer T, et al. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K. FASEB J 2008; 22:3059-3067.
39. Sato Y, Tsuboi R, Lyons R, et al. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 1990; 111:757-763.
40. Fabian SL, Penchev RR, St-Jacques B, et al. Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol 2012; 180:1441-1453.
41. Ding H, Zhou D, Hao S, et al. Sonic hedgehog signaling mediates epithelialmesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol 2012; 23:801-813.
42. Foo SS, Turner CJ, Adams S, et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 2006; 124:161-173.
43. Salvucci O, Maric D, Economopoulou M, et al. Ephrin B reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood 2009; 114:1707-1716.
44. Kida YLN, Schrimpf C, Reyes M, Duffield JS. Defective ephrin B2 reverse signaling promotes capillary rarefaction and fibrosis after kidney injury. J Am Soc Nephrol 2013; 24:559-572.
45. Basile DP, Fredrich K, Chelladurai B, et al. Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J Physiol Renal Physiol 2008; 294:F928-936.
46. Jonsson-Rylander AC, Nilsson T, Fritsche-Danielson R, et al. Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 2005; 25:180-185.
47. Chau BN, Xin C, Hartner J, et al. Micro RNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 2012; 4:121ra18.
48. Godwin JG, Ge X, Stephan K, et al. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A 2010; 107: 14339-14344.
49. Zarjou A, Yang S, Abraham E, et al. Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol 2011; 301:F793-F801.
50. Zhong X, Chung AC, Chen HY, et al. Lan HY. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 2013; 56:663-674.
51. El-Achkar TM. Modulation of apoptosis by ischemic preconditioning: an emerging role for miR-21. Kidney Int 2012; 82:1149-1151.
52. Denby L, Ramdas V, McBride MW, et al. miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol 2011; 179:661-672.
53. Dey N, Das F, Mariappan MM, et al. MicroRNA-21 orchestrates high glucoseinduced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J Biol Chem 2011; 286:25586-25603.
54. Duffield JS, Lupher MLJJr. PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis. Drug News Perspect 2010; 23:305-315.